Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label extension trial conducted at the same European sites that
participated in trial SP 709 (NCT00243217). The trial is designed to collect long-term safety
and tolerability, efficacy correlates, and quality of life data in subjects with idiopathic
Restless Leg Syndrome (RLS). The duration of treatment is approximately 5 years. Subject will
be up-titrated to their optimal dose (administration of 1 patch per day, 5 different doses
and patch sizes).